Reassessing Surgery Eligibility for Smoking Lung Cancer Patients

Researchers at the University of Cincinnati College of Medicine discovered that lung cancer patients who continue smoking before surgery experience more pulmonary complications (34.6% vs. 30.5% for non-smokers) but face no difference in short-term mortality rates (1% for both groups). The study, published in the *Journal of the American College of Surgeons*, analyzed data from 85,124 patients registered between 2018 and 2023 in the Society of Thoracic Surgeons General Thoracic Surgery Database. Lead author Hannah Kim, MD, and colleagues found that current smokers were younger and had fewer comorbidities, yet their higher complication rates suggest a need for tailored surgical approaches. Robert Van Haren, MD, associate professor of clinical surgery and corresponding author, emphasized that while smoking increases post-operative risks, surgeons should evaluate patients individually rather than excluding them solely based on smoking status. Traditionally, surgeons required patients to quit smoking one month before surgery, but Van Haren noted that advancements in robot-assisted surgery—using smaller incisions—have improved recovery outcomes, reducing risks like pneumonia compared to open thoracotomy procedures. The study highlights that technology and evolving medical knowledge now allow more patients to undergo surgery safely, even if they cannot quit smoking beforehand. Van Haren stressed that while smoking remains harmful and linked to cancer and heart disease, the findings do not establish causation but indicate a correlation. Surgeons will still consider factors like age, mobility, and cancer type when deciding on surgical eligibility. The research underscores the importance of personalized medicine in lung cancer treatment, balancing risks and benefits for each patient.